Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (351-360 of 415) with videos related to

Pageof 42
Sort By:
Scientific Reports|September 8, 2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt studyLaura Pizzuti, Paolo Marchetti, Clara Natoli, et al.
The Oncologist|November 23, 2023
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL StudyAndrea Botticelli, Roberta Caputo, Simone Scagnoli, et al.
Tumori|September 20, 2023
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian surveyBruna Cerbelli, Alessio Cirillo, Giulia Pomati, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Journal of Translational Medicine|November 16, 2019
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practiceAlessio Cortellini, Maria G Vitale, Federica De Galitiis, et al.
Tumori|February 18, 2015
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter studyMichele De Tursi, Consiglia Carella, Silverio Tomao, et al.
Critical Reviews in Oncology/Hematology|December 13, 2021
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific SocietiesAntonio Russo, Lorena Incorvaia, Ettore Capoluongo, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.
Cancers|January 30, 2019
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal CancerCarlo Capalbo, Francesca Belardinilli, Domenico Raimondo, et al.
Journal of Cellular Physiology|July 16, 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life settingTeresa Gamucci, Laura Pizzuti, Isabella Sperduti, et al.
Pageof 42

Showing results (351-360 of 415) with videos related to

Sort By:
Pageof 42
Scientific Reports|September 8, 2017
Fasting glucose and body mass index as predictors of activity in breast cancer patients treated with everolimus-exemestane: The EverExt studyLaura Pizzuti, Paolo Marchetti, Clara Natoli, et al.
The Oncologist|November 23, 2023
Real-World Outcomes of Trastuzumab Deruxtecan in Patients With HER2+ Metastatic Breast Cancer: The DE-REAL StudyAndrea Botticelli, Roberta Caputo, Simone Scagnoli, et al.
Tumori|September 20, 2023
PD-L1 testing in metastatic triple negative breast cancer: Results of an Italian surveyBruna Cerbelli, Alessio Cirillo, Giulia Pomati, et al.
Diagnostics (Basel, Switzerland)|October 12, 2019
<i>BRCA1/2</i> Molecular Assay for Ovarian Cancer Patients: A Survey through Italian Departments of Oncology and Molecular and Genomic Diagnostic LaboratoriesEttore Capoluongo, Nicla La Verde, Massimo Barberis, et al.
Journal of Translational Medicine|November 16, 2019
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practiceAlessio Cortellini, Maria G Vitale, Federica De Galitiis, et al.
Tumori|February 18, 2015
Chemotherapy-induced nausea and vomiting in Italian cancer centers: results of CINVDAY, a prospective, multicenter studyMichele De Tursi, Consiglia Carella, Silverio Tomao, et al.
Critical Reviews in Oncology/Hematology|December 13, 2021
The challenge of the Molecular Tumor Board empowerment in clinical oncology practice: A Position Paper on behalf of the AIOM- SIAPEC/IAP-SIBioC-SIC-SIF-SIGU-SIRM Italian Scientific SocietiesAntonio Russo, Lorena Incorvaia, Ettore Capoluongo, et al.
Critical Reviews in Oncology/Hematology|June 9, 2019
Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relativesStefania Gori, Massimo Barberis, Maria Angela Bella, et al.
Cancers|January 30, 2019
A Simplified Genomic Profiling Approach Predicts Outcome in Metastatic Colorectal CancerCarlo Capalbo, Francesca Belardinilli, Domenico Raimondo, et al.
Journal of Cellular Physiology|July 16, 2017
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life settingTeresa Gamucci, Laura Pizzuti, Isabella Sperduti, et al.
Pageof 42